Literature DB >> 9571081

Computer modeling of size and shape descriptors of alpha 1-adrenergic receptor antagonists and quantitative structure-affinity/selectivity relationships.

M Montorsi1, M C Menziani, M Cocchi, F Fanelli, P G De Benedetti.   

Abstract

Computational chemistry and molecular modeling procedures allow us to define and compute ad hoc size and shape descriptors on the different prototropic forms assumed by drugs in biotest solutions. Together with experimental data measured on a well-identified target receptor, these descriptors are essential elements for obtaining simple, consistent, comparable, and easily interpretable theoretical quantitative structure-activity relationship (QSAR) models based on the ligand similarity-target receptor complementarity paradigm. In this context, quantitative size and shape affinity/subtype selectivity relationships have been modeled for a large set of very heterogeneous alpha 1a-, alpha 1b-, and alpha 1c-adrenergic receptor antagonists. The linear QSAR models generated have been validated by predicting both binding affinity and selectivity of a test set of noncongeneric antagonists. The satisfactory results obtained highlight both the simplicity and the versatility of the approach presented.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9571081     DOI: 10.1006/meth.1998.0581

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  2 in total

1.  Quantitative structure-activity relationships of alpha1 adrenergic antagonists.

Authors:  Slavica Eric; Tomaz Solmajer; Jure Zupan; Marjana Novic; Marko Oblak; Danica Agbaba
Journal:  J Mol Model       Date:  2004-03-03       Impact factor: 1.810

2.  Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA) studies on α(1A)-adrenergic receptor antagonists based on pharmacophore molecular alignment.

Authors:  Xin Zhao; Minsheng Chen; Biyun Huang; Hong Ji; Mu Yuan
Journal:  Int J Mol Sci       Date:  2011-10-20       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.